Sorena Alikhan-Kiani
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Management of hereditary angioedema in the UK: a comparison with international guidelines.
Journal: Clinical and experimental immunology
Published: June 17, 2026
Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity.
Journal: Bone marrow transplantation
Published: April 26, 2026
Hereditary Angioedema: On-demand Treatment and Long-term Prophylaxis - A Global Reality.
Journal: Clinical and experimental immunology
Published: March 27, 2026
The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities.
Journal: The World Allergy Organization journal
Published: January 14, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.
Journal: The World Allergy Organization journal
Published: December 22, 2025
A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee.
Journal: Frontiers in immunology
Published: December 22, 2025
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-S.
Journal: The journal of allergy and clinical immunology. Global
Published: December 01, 2025
Risk factors and surrogate indicators for cardiovascular disease are prevalent in Common Variable Immunodeficiency and associate with inflammatory phenotype.
Journal: Frontiers in immunology
Published: November 28, 2025
Berotralstat and Health-Related Quality of Life in Hereditary Angioedema: Pooled Analysis of the APeX-2 and APeX-J Trials.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: October 22, 2025
An International Delphi Study on Barriers to On-Demand Treatment of Hereditary Angioedema Attacks.
Journal: Clinical and translational allergy
Published: October 21, 2025
Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Haematology
Published: September 08, 2025
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Haematology
Published: August 25, 2025
Last Updated: 09/26/2026